Protein unmasks pathogenic fungi to activate immune response

August 8, 2011 in Medical research

The first step in defending against a hostile attack is identifying the enemy. It's how a healthy immune system mounts a response to invading pathogens. In the case of certain fungi, however, the attacking cells may be so cleverly disguised that they're able to slip past our cellular guardians undetected and wreak havoc through infection. Such infections are a rising source of morbidity and mortality in healthy individuals, as well as in patients suffering from chronic diseases, such as cancer or AIDS.

The first step in defending against a hostile attack is identifying the enemy. It's how a healthy immune system mounts a response to invading pathogens. In the case of certain fungi, however, the attacking cells may be so cleverly disguised that they're able to slip past our cellular guardians undetected and wreak havoc through infection. Such infections are a rising source of morbidity and mortality in healthy individuals, as well as in patients suffering from , such as cancer or AIDS.

In this week's issue of the journal (PNAS), Whitehead Institute scientists describe a mechanism by which can distinguish between pathogenic and non-pathogenic fungi and modulate the accordingly.

The work builds on earlier research that identified how certain immune cells, called , determine whether a foreign cell is a fungus. The protein dectin-1, which resides in the macrophage , recognizes beta-glucan, a that supports the cell walls of fungi. Once dectin-1 detects beta-glucan, indicating the presence of a fungal threat, it can trigger many responses in its macrophage, including engulfment of the fungal cell; production of reactive (ROS) that are toxic to the fungal cell; and secretion of and chemokines that recruit other immune cells to the fight.

To observe dectin-1's activity in living cells, researchers in the labs of Whitehead Founding Member Gerald Fink and Member Hidde Ploegh collaborated to tag the protein while integrated into the cell membranes of macrophages. Maximilian Popp, a former graduate student in the Ploegh lab, had refined this tagging method, which does not interfere with normal cell functions. Earlier tagging methods had relied on attaching a bulky green fluorescent protein (GFP) to the protein of interest. Although GFP tagging is a valuable research method, it can induce unwanted changes in protein and cellular behavior.

"For a lot of proteins, GFP tagging is incompatible with their function because the GFP is so big, about 25 kilodaltons," says Popp. "We were trying to avoid this by attaching a very, very small, about 2 kilodalton tag that is very bright. They're so small that they don't have the negative effects that GFP does. And the tags attach to dectin at the exclusion of all of the other cell surface molecules of the same cell."

Using Popp's method, called sortagging, Alexandre Esteban, a postdoctoral researcher in the Fink lab and first author of the PNAS paper, determined that dectin-1 associates with the protein galectin-3 in macrophages. Although known to recognize pathogenic fungi, galectin-3's specific role in the immune response to fungi had yet to be identified.

According to Esteban's work on established cell lines and mouse macrophages, galectin-3 supplements a major weakness of dectin-1. The dectin-1-dependent immune response hinges on dectin-1's ability to recognize beta-glucan. But over the millennia of human/fungal interactions, have evolved to mask their beta-glucan with something of a "shag carpet" of proteins and other sugar molecules on their cell surfaces.

Galectin-3 recognizes and then binds to specific sugar molecules from this outer layer that are only present in the pathogen Candida albicans. Such recognition flags the fungal cells as pathogens and modulates dectin-1's immune responses.

"Until now, we didn't know that dectin-1 requires a partner to modulate its response, depending on if the fungi are pathogenic or non-pathogenic," says Esteban. "With this work, we determined the way that immune cells discriminate between pathogenic and non-pathogenic fungi."

Esteban notes that research studying galectin-3 and its role in the immune system should enhance our understanding of invasive fungal infections and may one day lead to discovery of novel targets for antifungal drugs.

More information: "Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages," PNAS, the week of August 8-12, 2011

Provided by Whitehead Institute for Biomedical Research search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Implantable pain disk may help those with cancer

An estimated 3.5 million cancer patients around the globe are in severe pain from their disease, but many get no relief.

Medical research created 14 hours ago | popularity not rated yet | comments 0 | with audio podcast

Energy levels link sleep control mechanisms

Sleep, or lack of it, can determine level of cognitive performance which is linked with accidents as well as increased risk of serious health problems. Links between cell energy levels, gene transcription ...

Medical research created 16 hours ago | popularity not rated yet | comments 0

Researchers identify key brain cell in antidepressant action

(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.

Medical research created 16 hours ago | popularity 4 / 5 (1) | comments 0 | with audio podcast

Rockefeller scientists pioneer new method to determine mechanisms of drug action

(Medical Xpress) -- Knowing that a drug works is great. Knowing how it works is a luxury. And until now, determining a drug’s mechanism of action has been a tedious and difficult process for scientists.

Medical research created 17 hours ago | popularity not rated yet | comments 0 | with audio podcast

Like curry? New biological role identified for compound used in ancient medicine

Scientists have just identified a new reason why some curry dishes, made with spices humans have used for thousands of years, might be good for you.

Medical research created May 25, 2012 | popularity 4.3 / 5 (9) | comments 2 | with audio podcast


Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...